1. Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
   Yingmiao Liu et al, 2014, Cancer Med CrossRef
2. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo
   Xin-Ping Li et al, 2015, BMC Cancer CrossRef
3. miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4
   Qi Xu et al, 2017, PLoS ONE CrossRef
4. null
   Georgina Gonzalez-Avila et al, 2020 CrossRef